Literature DB >> 23993836

Malignant insulinoma: recommendations for characterisation and treatment.

Eric Baudin1, Philippe Caron, Catherine Lombard-Bohas, Antoine Tabarin, Emmanuel Mitry, Yves Reznick, David Taieb, François Pattou, Pierre Goudet, Delphine Vezzosi, Jean-Yves Scoazec, Guillaume Cadiot, Françoise Borson-Chazot, Christine Do Cao.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23993836     DOI： 10.1016/j.ando.2013.07.001

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN： 0003-4266            Impact factor:   2.478


× No keyword cloud information.
  16 in total

Review 1.  Treatment of symptomatic neuroendocrine tumor syndromes: recent advances and controversies.

Authors:  Tetsuhide Ito; Lingaku Lee; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2016-09-23       Impact factor: 3.889

Review 2.  Management of functional neuroendocrine tumors of the pancreas.

Authors:  Kjell Öberg
Journal:  Gland Surg       Date:  2018-02

3.  Malignant Insulinoma: A Rare Form of Neuroendocrine Tumor.

Authors:  Alaa Sada; Amy E Glasgow; Adrian Vella; Geoffrey B Thompson; Travis J McKenzie; Elizabeth B Habermann
Journal:  World J Surg       Date:  2020-07       Impact factor: 3.352

4.  The incidence of insulinoma in Western Sweden between 2002 and 2019.

Authors:  Ellinor Svensson; Andreas Muth; Per Hedenström; Oskar Ragnarsson
Journal:  Ann Gastroenterol       Date:  2022-03-25

Review 5.  Malignant insulinoma: Can we predict the long-term outcomes?

Authors:  Maja Cigrovski Berkovic; Monika Ulamec; Sonja Marinovic; Ivan Balen; Anna Mrzljak
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

Review 6.  The treatment of hyperinsulinemic hypoglycaemia in adults: an update.

Authors:  M V Davi; A Pia; V Guarnotta; G Pizza; A Colao; A Faggiano
Journal:  J Endocrinol Invest       Date:  2016-09-13       Impact factor: 4.256

7.  ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors.

Authors:  M Falconi; B Eriksson; G Kaltsas; D K Bartsch; J Capdevila; M Caplin; B Kos-Kudla; D Kwekkeboom; G Rindi; G Klöppel; N Reed; R Kianmanesh; R T Jensen
Journal:  Neuroendocrinology       Date:  2016-01-05       Impact factor: 4.914

8.  A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.

Authors:  Mark Anthony Sandoval; Daveric Pagsisihan; A'Ericson Berberabe; Elaine Gayle Palugod-Lopez
Journal:  BMJ Case Rep       Date:  2016-03-18

Review 9.  Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations.

Authors:  Benjamin Chevalier; Hippolyte Dupuis; Arnaud Jannin; Madleen Lemaitre; Christine Do Cao; Catherine Cardot-Bauters; Stéphanie Espiard; Marie Christine Vantyghem
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-06       Impact factor: 5.555

Review 10.  Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management.

Authors:  Francesca Spada; Roberta E Rossi; Elda Kara; Alice Laffi; Sara Massironi; Manila Rubino; Franco Grimaldi; Sherrie Bhoori; Nicola Fazio
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.